Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis - PubMed (original) (raw)

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

L Coscoy et al. Proc Natl Acad Sci U S A. 2000.

Erratum in

Abstract

Down-regulation of the cell surface display of class I MHC proteins is an important mechanism of immune evasion by human and animal viruses. Herpesviruses in particular encode a variety of proteins that function to lower MHC I display by several mechanisms. These include binding and retention of MHC I chains in the endoplasmic reticulum, dislocation of class I chains from the ER, inhibition of the peptide transporter (TAP) involved in antigen presentation, and shunting of newly assembled chains to lysosomes. Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a human herpesvirus strongly linked to the development of KS and to certain AIDS-associated lymphoproliferative disorders. Here we show that KSHV encodes two distinctive gene products that function to dramatically reduce cell surface MHC I expression. These viral proteins are localized predominantly to the ER. However, unlike previously described MHC I inhibitors, they do not interfere with the synthesis, translocation, or assembly of class I chains, nor do they retain them in the ER. Rather, they act to enhance endocytosis of MHC I from the cell surface; internalized class I chains are delivered to endolysosomal vesicles, where they undergo degradation. These KSHV proteins define a mechanism of class I down-regulation distinct from the mechanisms of other herpesviruses and are likely to contribute importantly to immune evasion during viral infection.

PubMed Disclaimer

Figures

Figure 1

Figure 1

(A) Detection of MHC I molecules in HeLa cells stably transduced with retrovirus vectors expressing the different K genes. After infection, cells were selected in the presence of geneticin for 2 weeks; colonies were pooled and stained by flow cytometry with a monoclonal anti-HLA A,B,C antibody directly conjugated to fluorescein. Results presented correspond to the intensity of fluorescein fluorescence of the HeLa cells analyzed by flow cytometry. (B) BJAB cells stably transfected with pcdef3-K5 (solid lines) or the pcdef3 vector alone (dashed lines) were stained with mAbs specific for MHC I (Upper Left), CD58 (Upper Right), MHC II (Lower Left), or CD95 (Lower Right) and analyzed by flow cytometry. (C) Alignment of K3 and K5. Bold characters correspond to identity, rectangles represent the two putative transmembrane domains predicted by the program

psort

(10), and underlined sequences represent the putative ring finger motif.

Figure 2

Figure 2

(A) Intracellular localization of K3. HeLa cells grown on coverslips were transfected with expression vectors for the HA-tagged version of K3 (HA-K3) plus KDEL-GFP. Cells were stained 36 h posttransfection as described in Materials and Methods. HA-K3 was detected with a rabbit polyclonal anti-HA followed by a goat anti-rabbit IgG rhodamine conjugate. (B) Localization of MHC I molecules in K3- and K5-expressing HeLa cells. HeLa cells were transfected with vector alone (Lower) or HA-tagged version of K3 (Upper). Cells were stained 36 h posttransfection. MHC I molecules were visualized by staining with the monoclonal W6/32 antibody followed by a goat anti-mouse IgG rhodamine conjugate. HA-K3 was detected with a rabbit anti-HA revealed by goat anti-rabbit fluorescein conjugate.

Figure 3

Figure 3

Intracellular transport and stability of MHC I molecules. (A) HeLa cells stably transfected with pCEP4-K3 (Lower) or the pCEP4 vector alone (Upper) were metabolically labeled for 20 min and chased for the indicated time periods. After being lysed in 1% Nonidet P-40, lysates were divided into three aliquots. Two were kept on ice and one was incubated at 37°C for 1 h. Heterodimeric MHC I molecules were immunoprecipitated with mAb W6/32 and treated with endo H where indicated. (B) BJAB cells stably transfected with pcdef3-K5 or the vector alone were radiolabeled for 30 min and chased for the indicated time periods. MHC I molecules in cell lysates were immunoprecipitated with mAb W6/32. Quantitation of the data is presented as a fraction of initial MHC I levels; ⋄, K5 expressing cells; ●, control cells. (C) BJAB cells stably transfected with pcdef3-K5 were radiolabeled for 30 min and chased for 3 h in the presence or absence of the indicated inhibitors. MHC I molecules were immunoprecipitated by using mAb W6/32.

Figure 4

Figure 4

(A) Kinetics of decrease of surface-bound anti-MHC I mAb in BJAB cells stably transfected with pcdef3-K5 or the pcdef3 vector. Cells were labeled at 4°C with the anti-MHC I mAb W6/32, washed, and incubated at 37°C for the indicated periods. Cells then were cooled to 4°C and stained with goat anti-mouse IgG fluorescein conjugate. Surface levels of W6/32-MHC I complexes were analyzed by flow cytometry. The initial values (t = 0) were standardized to 100, corresponding to 200 fluorescence units for BJAB pcdef3-K5 and 1100 fluorescence units for BJAB pcdef3. Data are expressed as the percentage of the initial values. □, Cells bearing pcdef3 vector alone; ⋄, pcdef3-K5-expressing cells. (B) Susceptibility of K5-induced MHC I endocytosis to a dominant-negative dynamin-1 mutant. BJAB cells (Upper) or BJAB-K5 cells (Lower) were transfected with 21 μg of dynamin-1 wild type (WT; left) and 4 μg of an EGFP expression vector or with 21 μg of the dynamin-1 trans-dominant-negative (K44E; Right) and 4 μg of an EGFP expression vector. After 36 h, cells were incubated with mAb W6/32 and W6/32-bound MHC I surface molecules were revealed by a fluorescein-conjugated goat anti-mouse antibody and analyzed by flow cytometry. (C) Kinetics of MHC I export to the cell surface. BJAB stably transfected with pcdef3-K5 (⋄) or the vector alone (□) were labeled at 4°C with an excess of MHC I mAb W6/32 to saturate the preexisting surface MHC I molecules. Cells were washed and incubated at 37°C in the presence of a MHC I mAb W6/32 fluorescein conjugate for the indicated periods of time. Cells were analyzed by flow cytometry. (D) Effect of K5 expression on preexisting surface MHC I molecules. BJAB cells were transfected with 20 μg of pIRES2-EGFP (thin lines) or pK5-IRES2-EGFP (thick lines). Immediately after transfection, cells were labeled for 1 h at 4°C with mAb W6/32 or with a mAb against CD58, washed, and returned to the 37°C incubator. Thirty-six hours after transfection, surface-labeled MHC I (b) or CD58 (a) in cells displaying GFP expression was detected by flow cytometry using a goat anti-mouse IgG R-phycoerythrin conjugate.

Similar articles

Cited by

References

    1. Ahn K, Angulo A, Ghazal P, Peterson P A, Yang Y, Fruh K. Proc Natl Acad Sci USA. 1996;93:10990–10995. - PMC - PubMed
    1. Jones T R, Wiertz E J, Sun L, Fish K N, Nelson J A, Ploegh H L. Proc Natl Acad Sci USA. 1996;93:11327–11333. - PMC - PubMed
    1. Reusch U, Muranyi W, Lucin P, Burgert H G, Hengel H, Koszinowski U H. EMBO J. 1999;18:1081–1091. - PMC - PubMed
    1. Wiertz E J, Jones T R, Sun L, Bogyo M, Geuze H J, Ploegh H L. Cell. 1996;84:769–779. - PubMed
    1. Whitby D, Boshoff C. Curr Opin Oncol. 1998;10:405–412. - PubMed

MeSH terms

Substances

LinkOut - more resources